marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-13-2024
Mersana Therapeutics Cash Flow 2011-2024 | MRSN
Annual Cash Flow Mersana Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-169 M | -49.4 M | -140 M | -74.7 M | -67.7 M | -55.2 M | -42.7 M | 31.6 M | -9.64 M | - | - | - | - |
Depreciation & Amortization |
1.52 M | 927 K | 855 K | 1.01 M | 1.24 M | 1.26 M | 928 K | 655 K | 297 K | - | - | - | - |
Accounts Payables |
7.32 M | 14 M | 12.3 M | 8.34 M | 7.3 M | 10.7 M | 3.07 M | - | - | - | - | - | - |
Accounts Receivables |
- | 30 M | - | - | - | 459 K | 784 K | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Mersana Therapeutics
| 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | - | - | - | -29 M | - | 1.87 M | -52.7 M | -7.96 M | - | -97.6 M | -61.5 M | -27 M | - | -57.4 M | -37.2 M | -21.2 M | - | -55.2 M | -14.2 M | -24.7 M | - | -39.3 M | -28.8 M | -17.4 M | - | -31.7 M | -20.6 M | -10.9 M | - | 18.4 M | 23.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | - | - | - | 319 K | - | 645 K | 432 K | 205 K | - | 644 K | 432 K | 226 K | - | 750 K | 494 K | 248 K | - | 963 K | 653 K | 337 K | - | 907 K | 565 K | 258 K | - | 673 K | 438 K | 209 K | - | 449 K | 265 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
2.03 M | 3.01 M | 7.32 M | 12.9 M | 16.9 M | 18.2 M | 14 M | 13.7 M | 8.16 M | 9.78 M | 12.3 M | 5.87 M | 10.6 M | 11.7 M | 8.34 M | 8.34 M | 8.34 M | 8.34 M | 7.3 M | 7.3 M | 7.3 M | 7.3 M | 10.7 M | 10.7 M | 10.7 M | 10.7 M | 3.07 M | 3.07 M | 3.07 M | 3.07 M | 2.07 M | 2.07 M | 2.07 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
1 M | 1.57 M | - | - | - | - | 30 M | - | - | - | - | - | - | - | - | - | - | - | - | 298 K | 288 K | 468 K | 459 K | 459 K | 459 K | 459 K | 784 K | 784 K | 784 K | 784 K | 1.05 M | 1.05 M | 1.05 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency